RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series - Carothers - - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library https://t.co/uP1PAeISD4
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @tipssovetorax: Acetil cisteina en el tratamiento de complicaciones hepáticas por remdesivir en #COVID19. Serie de casos. @SOVETORAX @SV…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @doctorira: Oh.
RT @Biomaven: Acute liver failure associated with Remdesivir: https://t.co/82v5joXSfD
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @sales_js: $HGEN Lenzi Mayo Clinic’s data have a better efficacy and safety profiles than dexamethazone and Remdesivir
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
Oh.
RT @PharmERToxGuy: Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases…
Remdesivir for #COVID19 is not without risk (see serious adverse event table from 10/8/20 NEJM final report). Two cases of suspected remdesivir‐associated acute liver failure just published. Acetylcysteine may help treat it. https://t.co/DER4GHDwO4 https:
Acetil cisteina en el tratamiento de complicaciones hepáticas por remdesivir en #COVID19. Serie de casos. @SOVETORAX @SVMI_Nacional @svinfectologia https://t.co/U8trk5PFH5
RT @Biomaven: Acute liver failure associated with Remdesivir: https://t.co/82v5joXSfD
Management of suspected remdesivir-associated acute liver failure: A small case series https://t.co/iTDVf20BbY Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/oh9A14qb36
Management of suspected remdesivir-associated acute liver failure: A small case series https://t.co/iTDVf20BbY Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/PHCxdmtqlV
RT @Biomaven: Acute liver failure associated with Remdesivir: https://t.co/82v5joXSfD
@realDonaldTrump I am concerned with your health and just read this https://t.co/UgU9JQJFE3
$HGEN Lenzi Mayo Clinic’s data have a better efficacy and safety profiles than dexamethazone and Remdesivir
RT @Biomaven: Acute liver failure associated with Remdesivir: https://t.co/82v5joXSfD
Acute liver failure associated with Remdesivir: https://t.co/82v5joXSfD
RT @chanceycarother: Excited to get our experience published of managing suspected #remdesivir-induced acute liver failure in two patients…
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series https://t.co/igFwSTA93V
Excited to get our experience published of managing suspected #remdesivir-induced acute liver failure in two patients with #COVID19 in @PharmacoJournal @klbirrer
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series - Carothers - - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library https://t.co/hFZBHQdOSt
The data for the use of acetylcysteine to manage non‐acetaminophen‐induced acute liver failure is limited. A case series, free to download: https://t.co/cerGqM0qIZ @accpinfdprn #COVID19 https://t.co/uOdx8RMity
RT @MicrobLog_me_uk: Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series htt…
RT @canuckIDpharm: Lots of other contributing factors but this report of 2 patients with suspected remdesivir‐associated acute liver failur…
Very interesting indeed!
Interesting case reports -Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series- #TwitteRx
RT @canuckIDpharm: Lots of other contributing factors but this report of 2 patients with suspected remdesivir‐associated acute liver failur…
RT @jmanuelcaro: Acetilcisteina en sospecha de insuficiencia hepatica aguda asociada a remdesivir (2 casos) https://t.co/SJpFRcU05l
Acetilcisteina en sospecha de insuficiencia hepatica aguda asociada a remdesivir (2 casos) https://t.co/SJpFRcU05l
RT @Derek_Leong_RPh: 2 case reports of suspected remdesivir-associated acute liver failure treated with N-acetylcysteine infusion (21 hour…
@guy_70s @DrPhillipsMD I hope the five day course of remdesivir does less harm than the 10 days https://t.co/wLyo8RIPuw
2 case reports of suspected remdesivir-associated acute liver failure treated with N-acetylcysteine infusion (21 hour acetaminophen toxicity protocol). @DavidJuurlink @Pete_Wu @howard_h_an @JonZipursky https://t.co/bfHRzJyUTG
RT @MicrobLog_me_uk: Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series htt…
RT @MicrobLog_me_uk: Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series htt…
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series https://t.co/wnoJang4bH @bhogal_pathogen
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
RT @fdzaraf: COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデ…
COVID-19におけるレムデシビル関連性疑い急性肝不全に対するアセチルシステインの治療 https://t.co/o8w9kqCqEr #新型コロナウイルス ここでは、肝不全がアセチルシステインの持続注入とレムデシビルの中止により改善した、#レムデシビル と関係した急性肝不全 (ALF) の疑いのある2症例を報告する。
RT @PiePony1: @verycosmic Remdesivir is dangerous. Harms Renal, Liver, organs. Only reduces hospitalisation by a couple of days. Ivermectin…
RT @canuckIDpharm: Lots of other contributing factors but this report of 2 patients with suspected remdesivir‐associated acute liver failur…
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series https://t.co/dJk0pCRBXX
Lots of other contributing factors but this report of 2 patients with suspected remdesivir‐associated acute liver failure is concerning 😬 Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series ht
#raoult Le remdesivir endommage certains organes. Trump ne prend pas de remdesivir !
RT @SandmanRT: @jpkiekens It was known from Ebola that remdesivir causes liver failure so can add liver to kidneys. https://t.co/nPnruV3…
Study was seriously manipulated. Liver failure common. It’s a politically approved drug. Here’s the protocol they had to standardize because of the endemic liver failure with its use. https://t.co/urpWuH0b2l
RT @SandmanRT: @jpkiekens It was known from Ebola that remdesivir causes liver failure so can add liver to kidneys. https://t.co/nPnruV3…
@jpkiekens It was known from Ebola that remdesivir causes liver failure so can add liver to kidneys. https://t.co/nPnruV3d75
"Remdesivir is associated with acute liver failure" But, did anyone from medicine #Academics bothered to discuss about this 🤔 Any noise in the media #MSM ? NO #pandemic #COVID19 #BigPharma #Lobby #Corruption #profits #Lives https://t.co/HWGz1WonA6
@Covid19Crusher Shocked that President Trump is taking Remdesivir!!
@DrEricDing @GileadSciences @Regeneron Doesn't make sense. If it had a significant benefit, this would have been proven by now. While side effects appear to be not understood. https://t.co/2iQ6HbfYTN
https://t.co/9Pb2c0keib #DPC #DPC4Me Acetylcysteine to treat Remdesevir induced Acute Liver Failure
RT @Covid19Crusher: Academic research on how to tackle organ damage likely caused by remdesivir. Sadly, there is a need for such a thing. h…
RT @Covid19Crusher: Academic research on how to tackle organ damage likely caused by remdesivir. Sadly, there is a need for such a thing. h…
10-2-2020: COVID-19 patients in the U.S. have an extremely high incidence of liver damage after treatment, possibly from the virus, overweight, beef, sugar, or remdesivir. Here's a new study from Florida: https://t.co/mWKZ7XG3jy https://t.co/om0pvHLhsa h